This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Pediatric Adenotonsillectomy or Post Operative Analgesia
and you are
between 3 and 17
years old
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

The hypothesis of this study is that the administration of an intra-operative dose of dexmedetomidine will result in adequate analgesia without respiratory depression thereby resulting in an early discharge from the post anesthetic care unit following adenotonsillectomy.

Provided treatments

  • Drug: Dexmedetomidine 0.75 mcg/kg
  • Drug: Morphine 50 mcg/kg
  • Drug: Morphine 100 mcg/kg
  • Drug: Dexmedetomidine 1 mcg/kg

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01057381. The sponsor of the trial is Baylor College of Medicine and it is looking for 109 volunteers for the current phase.
Official trial title:
Dose Response Relationship of Dexmedetomidine in Decreasing Post Operative Analgesic Requirements in the Pediatric Tonsillectomy Patient